Msd R&d (china) Co., Ltd.

This study is testing a new drug called MK-1045 for people with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL) that has returned or is not responding to current treatments. The first part of the study aims to find a safe and effective dose. The second p…

This is the first study to test a new immunotherapy drug called MK-1045 in people. The goal is to find a safe dose and see if it can help patients with B-cell non-Hodgkin lymphoma that has come back or stopped responding to other treatments. Researchers will give the drug to abou…